nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—thymus cancer	0.878	1	CbGaD
Pseudoephedrine—IL2—neck—thymus cancer	0.0057	0.0918	CbGeAlD
Pseudoephedrine—NFATC1—hematopoietic system—thymus cancer	0.00464	0.0747	CbGeAlD
Pseudoephedrine—IL2—hematopoietic system—thymus cancer	0.00424	0.0683	CbGeAlD
Pseudoephedrine—IL2—epithelium—thymus cancer	0.00388	0.0624	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—thymus cancer	0.00326	0.0526	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—thymus cancer	0.00299	0.0481	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—thymus cancer	0.00297	0.0479	CbGeAlD
Pseudoephedrine—NFATC1—thyroid gland—thymus cancer	0.00296	0.0478	CbGeAlD
Pseudoephedrine—Paranoia—Octreotide—thymus cancer	0.00289	0.111	CcSEcCtD
Pseudoephedrine—IL2—bone marrow—thymus cancer	0.00272	0.0438	CbGeAlD
Pseudoephedrine—IL2—thyroid gland—thymus cancer	0.00271	0.0437	CbGeAlD
Pseudoephedrine—NFATC1—lung—thymus cancer	0.00269	0.0434	CbGeAlD
Pseudoephedrine—IL2—lung—thymus cancer	0.00246	0.0397	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—thymus cancer	0.00184	0.0297	CbGeAlD
Pseudoephedrine—TNF—lymph node—thymus cancer	0.00176	0.0283	CbGeAlD
Pseudoephedrine—IL2—lymph node—thymus cancer	0.00168	0.0271	CbGeAlD
Pseudoephedrine—IL2—T-Cell Receptor and Co-stimulatory Signaling—CD8A—thymus cancer	0.00167	0.0493	CbGpPWpGaD
Pseudoephedrine—TNF—Canonical NF-kappaB pathway—CYLD—thymus cancer	0.00153	0.0452	CbGpPWpGaD
Pseudoephedrine—Psychotic disorder—Octreotide—thymus cancer	0.0014	0.0538	CcSEcCtD
Pseudoephedrine—Irritability—Octreotide—thymus cancer	0.00136	0.0526	CcSEcCtD
Pseudoephedrine—Dysuria—Octreotide—thymus cancer	0.00115	0.0445	CcSEcCtD
Pseudoephedrine—SLC6A3—hematopoietic system—thymus cancer	0.00112	0.018	CbGeAlD
Pseudoephedrine—MAOA—neck—thymus cancer	0.00112	0.018	CbGeAlD
Pseudoephedrine—NFATC1—Calcium signaling in the CD4+ TCR pathway—IL2—thymus cancer	0.00104	0.0308	CbGpPWpGaD
Pseudoephedrine—SLC6A4—hematopoietic system—thymus cancer	0.00103	0.0165	CbGeAlD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.00102	0.0302	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokines and Inflammatory Response—CD4—thymus cancer	0.00102	0.03	CbGpPWpGaD
Pseudoephedrine—Bradycardia—Octreotide—thymus cancer	0.00101	0.0388	CcSEcCtD
Pseudoephedrine—NFATC1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—thymus cancer	0.00099	0.0292	CbGpPWpGaD
Pseudoephedrine—IL2—IL12-mediated signaling events—CD8A—thymus cancer	0.000933	0.0275	CbGpPWpGaD
Pseudoephedrine—IL2—IL12 signaling mediated by STAT4—CD4—thymus cancer	0.000933	0.0275	CbGpPWpGaD
Pseudoephedrine—Arrhythmia—Octreotide—thymus cancer	0.000883	0.034	CcSEcCtD
Pseudoephedrine—TNF—TNF receptor signaling pathway —CYLD—thymus cancer	0.000879	0.026	CbGpPWpGaD
Pseudoephedrine—IL2—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.000865	0.0255	CbGpPWpGaD
Pseudoephedrine—Tension—Octreotide—thymus cancer	0.000844	0.0325	CcSEcCtD
Pseudoephedrine—ADRA1A—hematopoietic system—thymus cancer	0.00084	0.0135	CbGeAlD
Pseudoephedrine—Nervousness—Octreotide—thymus cancer	0.000836	0.0322	CcSEcCtD
Pseudoephedrine—MAOA—hematopoietic system—thymus cancer	0.000833	0.0134	CbGeAlD
Pseudoephedrine—Muscle spasms—Octreotide—thymus cancer	0.000827	0.0319	CcSEcCtD
Pseudoephedrine—ADRB1—cardiac atrium—thymus cancer	0.000807	0.013	CbGeAlD
Pseudoephedrine—Tremor—Octreotide—thymus cancer	0.000806	0.0311	CcSEcCtD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—CD8A—thymus cancer	0.000798	0.0235	CbGpPWpGaD
Pseudoephedrine—Agitation—Octreotide—thymus cancer	0.000791	0.0305	CcSEcCtD
Pseudoephedrine—IL2—IL23-mediated signaling events—CD4—thymus cancer	0.000789	0.0233	CbGpPWpGaD
Pseudoephedrine—Vertigo—Octreotide—thymus cancer	0.000773	0.0298	CcSEcCtD
Pseudoephedrine—ADRA1A—epithelium—thymus cancer	0.000768	0.0124	CbGeAlD
Pseudoephedrine—Palpitations—Octreotide—thymus cancer	0.00076	0.0293	CcSEcCtD
Pseudoephedrine—Hypertension—Octreotide—thymus cancer	0.000743	0.0286	CcSEcCtD
Pseudoephedrine—Chest pain—Octreotide—thymus cancer	0.000732	0.0282	CcSEcCtD
Pseudoephedrine—Anxiety—Octreotide—thymus cancer	0.00073	0.0281	CcSEcCtD
Pseudoephedrine—Tachycardia—Octreotide—thymus cancer	0.000685	0.0264	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Octreotide—thymus cancer	0.000679	0.0262	CcSEcCtD
Pseudoephedrine—NFATC1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.000675	0.0199	CbGpPWpGaD
Pseudoephedrine—Anorexia—Octreotide—thymus cancer	0.000669	0.0258	CcSEcCtD
Pseudoephedrine—SLC6A3—lung—thymus cancer	0.000651	0.0105	CbGeAlD
Pseudoephedrine—ADRA2A—hematopoietic system—thymus cancer	0.000639	0.0103	CbGeAlD
Pseudoephedrine—Insomnia—Octreotide—thymus cancer	0.000635	0.0245	CcSEcCtD
Pseudoephedrine—MAOA—cardiac atrium—thymus cancer	0.000632	0.0102	CbGeAlD
Pseudoephedrine—Dyspnoea—Octreotide—thymus cancer	0.000626	0.0241	CcSEcCtD
Pseudoephedrine—Dyspepsia—Octreotide—thymus cancer	0.000618	0.0238	CcSEcCtD
Pseudoephedrine—MAOA—pituitary gland—thymus cancer	0.000618	0.00995	CbGeAlD
Pseudoephedrine—ADRB1—lung—thymus cancer	0.000617	0.00994	CbGeAlD
Pseudoephedrine—Decreased appetite—Octreotide—thymus cancer	0.00061	0.0235	CcSEcCtD
Pseudoephedrine—Pain—Octreotide—thymus cancer	0.0006	0.0231	CcSEcCtD
Pseudoephedrine—SLC6A4—lung—thymus cancer	0.000596	0.00961	CbGeAlD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—CDKN2A—thymus cancer	0.000595	0.0176	CbGpPWpGaD
Pseudoephedrine—ADRA1A—lymphoid tissue—thymus cancer	0.000592	0.00953	CbGeAlD
Pseudoephedrine—Feeling abnormal—Octreotide—thymus cancer	0.000579	0.0223	CcSEcCtD
Pseudoephedrine—Body temperature increased—Octreotide—thymus cancer	0.000555	0.0214	CcSEcCtD
Pseudoephedrine—NFATC1—Downstream signaling in naïve CD8+ T cells—IL2—thymus cancer	0.00054	0.0159	CbGpPWpGaD
Pseudoephedrine—IL2—IL12-mediated signaling events—CD4—thymus cancer	0.000536	0.0158	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—KCNA4—thymus cancer	0.000533	0.0157	CbGpPWpGaD
Pseudoephedrine—MAOA—thyroid gland—thymus cancer	0.000533	0.00858	CbGeAlD
Pseudoephedrine—SLC6A2—lung—thymus cancer	0.000525	0.00846	CbGeAlD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—IL2—thymus cancer	0.000515	0.0152	CbGpPWpGaD
Pseudoephedrine—Asthenia—Octreotide—thymus cancer	0.000504	0.0194	CcSEcCtD
Pseudoephedrine—IL2—AP-1 transcription factor network—CDKN2A—thymus cancer	0.000503	0.0148	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—KCNA4—thymus cancer	0.000495	0.0146	CbGpPWpGaD
Pseudoephedrine—CYP2D6—hematopoietic system—thymus cancer	0.000495	0.00797	CbGeAlD
Pseudoephedrine—ADRA2A—cardiac atrium—thymus cancer	0.000485	0.00782	CbGeAlD
Pseudoephedrine—MAOA—lung—thymus cancer	0.000484	0.00779	CbGeAlD
Pseudoephedrine—IL2—T-Cell Receptor and Co-stimulatory Signaling—AKT1—thymus cancer	0.000478	0.0141	CbGpPWpGaD
Pseudoephedrine—ADRA2A—pituitary gland—thymus cancer	0.000474	0.00763	CbGeAlD
Pseudoephedrine—Dizziness—Octreotide—thymus cancer	0.000464	0.0179	CcSEcCtD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—CD4—thymus cancer	0.000458	0.0135	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—IL2—thymus cancer	0.000454	0.0134	CbGpPWpGaD
Pseudoephedrine—Vomiting—Octreotide—thymus cancer	0.000446	0.0172	CcSEcCtD
Pseudoephedrine—Rash—Octreotide—thymus cancer	0.000443	0.0171	CcSEcCtD
Pseudoephedrine—Dermatitis—Octreotide—thymus cancer	0.000442	0.017	CcSEcCtD
Pseudoephedrine—Headache—Octreotide—thymus cancer	0.00044	0.017	CcSEcCtD
Pseudoephedrine—Nausea—Octreotide—thymus cancer	0.000417	0.0161	CcSEcCtD
Pseudoephedrine—ADRA2A—thyroid gland—thymus cancer	0.000409	0.00658	CbGeAlD
Pseudoephedrine—IL2—IL2 signaling events mediated by PI3K—AKT1—thymus cancer	0.000394	0.0116	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—CD4—thymus cancer	0.000378	0.0111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—lung—thymus cancer	0.000371	0.00598	CbGeAlD
Pseudoephedrine—IL2—IL-5 Signaling Pathway—AKT1—thymus cancer	0.00037	0.0109	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CYLD—thymus cancer	0.000369	0.0109	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CYLD—thymus cancer	0.000363	0.0107	CbGpPWpGaD
Pseudoephedrine—SLC6A2—lymph node—thymus cancer	0.000359	0.00578	CbGeAlD
Pseudoephedrine—TNF—IL27-mediated signaling events—IL2—thymus cancer	0.000358	0.0106	CbGpPWpGaD
Pseudoephedrine—IL2—IL-2 Signaling Pathway—AKT1—thymus cancer	0.000356	0.0105	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000349	0.0103	CbGpPWpGaD
Pseudoephedrine—TNF—Cytokines and Inflammatory Response—IL2—thymus cancer	0.000348	0.0103	CbGpPWpGaD
Pseudoephedrine—NFATC1—RANKL/RANK Signaling Pathway—AKT1—thymus cancer	0.000339	0.01	CbGpPWpGaD
Pseudoephedrine—NFATC1—AP-1 transcription factor network—TP53—thymus cancer	0.000331	0.00977	CbGpPWpGaD
Pseudoephedrine—MAOA—lymph node—thymus cancer	0.000331	0.00533	CbGeAlD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—CD8A—thymus cancer	0.000322	0.0095	CbGpPWpGaD
Pseudoephedrine—IL2—G beta:gamma signalling through PI3Kgamma—AKT1—thymus cancer	0.00032	0.00944	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—DPYSL5—thymus cancer	0.000317	0.00936	CbGpPWpGaD
Pseudoephedrine—IL2—GPVI-mediated activation cascade—AKT1—thymus cancer	0.000314	0.00928	CbGpPWpGaD
Pseudoephedrine—IL2—G-protein beta:gamma signalling—AKT1—thymus cancer	0.000304	0.00899	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—CD4—thymus cancer	0.000294	0.00867	CbGpPWpGaD
Pseudoephedrine—IL2—Folate Metabolism—TP53—thymus cancer	0.000293	0.00866	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.000292	0.00861	CbGpPWpGaD
Pseudoephedrine—NFATC1—BCR signaling pathway—AKT1—thymus cancer	0.000289	0.00854	CbGpPWpGaD
Pseudoephedrine—IL2—AP-1 transcription factor network—TP53—thymus cancer	0.00028	0.00826	CbGpPWpGaD
Pseudoephedrine—TNF—IL23-mediated signaling events—IL2—thymus cancer	0.00027	0.00797	CbGpPWpGaD
Pseudoephedrine—ADRA2A—lymph node—thymus cancer	0.000254	0.00409	CbGeAlD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—TP53—thymus cancer	0.000247	0.00728	CbGpPWpGaD
Pseudoephedrine—NFATC1—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.000246	0.00727	CbGpPWpGaD
Pseudoephedrine—IL2—Regulation of Telomerase—AKT1—thymus cancer	0.000242	0.00714	CbGpPWpGaD
Pseudoephedrine—NFATC1—TCR Signaling Pathway—AKT1—thymus cancer	0.000229	0.00675	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.000227	0.0067	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CYLD—thymus cancer	0.000215	0.00635	CbGpPWpGaD
Pseudoephedrine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—thymus cancer	0.000212	0.00627	CbGpPWpGaD
Pseudoephedrine—IL2—Glucocorticoid receptor regulatory network—AKT1—thymus cancer	0.000208	0.00615	CbGpPWpGaD
Pseudoephedrine—IL2—Corticotropin-releasing hormone—AKT1—thymus cancer	0.00019	0.00561	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—thymus cancer	0.000184	0.00544	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CYLD—thymus cancer	0.000182	0.00537	CbGpPWpGaD
Pseudoephedrine—TNF—Downstream signaling in naïve CD8+ T cells—IL2—thymus cancer	0.00017	0.00502	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—IL2—thymus cancer	0.00017	0.00502	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—thymus cancer	0.00017	0.00501	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—thymus cancer	0.000164	0.00485	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CDKN2A—thymus cancer	0.000162	0.00477	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MAML2—thymus cancer	0.000158	0.00466	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—IL2—thymus cancer	0.000147	0.00435	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—AKT1—thymus cancer	0.000139	0.00409	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—KIT—thymus cancer	0.000135	0.004	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000133	0.00393	CbGpPWpGaD
Pseudoephedrine—TNF—TWEAK Signaling Pathway—AKT1—thymus cancer	0.000132	0.00391	CbGpPWpGaD
Pseudoephedrine—TNF—Ceramide signaling pathway—AKT1—thymus cancer	0.000119	0.00351	CbGpPWpGaD
Pseudoephedrine—TNF—Angiopoietin receptor Tie2-mediated signaling—AKT1—thymus cancer	0.000115	0.0034	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MAML2—thymus cancer	0.000111	0.00326	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—thymus cancer	0.00011	0.00324	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—thymus cancer	0.000109	0.00322	CbGpPWpGaD
Pseudoephedrine—NFATC1—RNF mutants show enhanced WNT signaling and proliferation—AKT1—thymus cancer	0.000109	0.00322	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—IL2—thymus cancer	0.000107	0.00315	CbGpPWpGaD
Pseudoephedrine—TNF—Cardiac Hypertrophic Response—AKT1—thymus cancer	0.000107	0.00315	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD8A—thymus cancer	0.000105	0.0031	CbGpPWpGaD
Pseudoephedrine—TNF—Caspase Cascade in Apoptosis—AKT1—thymus cancer	0.000104	0.00306	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CD4—thymus cancer	0.000104	0.00306	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by WNT in cancer—AKT1—thymus cancer	0.000101	0.00299	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—thymus cancer	9.45e-05	0.00279	CbGpPWpGaD
Pseudoephedrine—IL2—Platelet activation, signaling and aggregation—AKT1—thymus cancer	9.42e-05	0.00278	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MAML2—thymus cancer	9.35e-05	0.00276	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—thymus cancer	9.29e-05	0.00274	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—thymus cancer	9e-05	0.00266	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD8A—thymus cancer	8.89e-05	0.00262	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by Wnt—AKT1—thymus cancer	8.35e-05	0.00246	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KIT—thymus cancer	7.89e-05	0.00233	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thymus cancer	7.6e-05	0.00224	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—thymus cancer	7.6e-05	0.00224	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KIT—thymus cancer	7.28e-05	0.00215	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—thymus cancer	7.19e-05	0.00212	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—AKT1—thymus cancer	7.07e-05	0.00209	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—thymus cancer	6.86e-05	0.00202	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KIT—thymus cancer	6.67e-05	0.00197	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—AKT1—thymus cancer	6.51e-05	0.00192	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—AKT1—thymus cancer	6.07e-05	0.00179	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—thymus cancer	6.03e-05	0.00178	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—thymus cancer	5.75e-05	0.0017	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—thymus cancer	5.57e-05	0.00164	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2—thymus cancer	5.55e-05	0.00164	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—thymus cancer	5.51e-05	0.00163	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—thymus cancer	5.19e-05	0.00153	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—thymus cancer	5.17e-05	0.00153	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—AKT1—thymus cancer	5.17e-05	0.00153	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—thymus cancer	5.1e-05	0.00151	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KIT—thymus cancer	5.1e-05	0.00151	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—thymus cancer	5.08e-05	0.0015	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—AKT1—thymus cancer	4.86e-05	0.00143	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	4.67e-05	0.00138	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—thymus cancer	4.66e-05	0.00137	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—AKT1—thymus cancer	4.37e-05	0.00129	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KIT—thymus cancer	4.31e-05	0.00127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—thymus cancer	4.1e-05	0.00121	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	3.94e-05	0.00116	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—thymus cancer	3.59e-05	0.00106	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—thymus cancer	3.07e-05	0.000906	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—thymus cancer	3.01e-05	0.000889	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAML2—thymus cancer	2.93e-05	0.000866	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAML2—thymus cancer	2.87e-05	0.000847	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—thymus cancer	2.79e-05	0.000823	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—thymus cancer	2.78e-05	0.000821	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—thymus cancer	2.55e-05	0.000752	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAML2—thymus cancer	2.37e-05	0.0007	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—thymus cancer	2.31e-05	0.00068	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—thymus cancer	2.22e-05	0.000656	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAML2—thymus cancer	2.2e-05	0.000651	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—thymus cancer	2.11e-05	0.000624	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—thymus cancer	1.95e-05	0.000576	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—thymus cancer	1.95e-05	0.000575	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—thymus cancer	1.84e-05	0.000544	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—thymus cancer	1.78e-05	0.000524	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—thymus cancer	1.74e-05	0.000513	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—thymus cancer	1.65e-05	0.000486	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—thymus cancer	1.61e-05	0.000476	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—thymus cancer	1.58e-05	0.000466	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—thymus cancer	1.44e-05	0.000424	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—thymus cancer	1.36e-05	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KIT—thymus cancer	1.35e-05	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—thymus cancer	1.34e-05	0.000394	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KIT—thymus cancer	1.32e-05	0.000391	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—thymus cancer	1.3e-05	0.000385	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—thymus cancer	1.21e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—thymus cancer	1.15e-05	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KIT—thymus cancer	1.1e-05	0.000323	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KIT—thymus cancer	1.02e-05	0.0003	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—thymus cancer	9.63e-06	0.000284	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—thymus cancer	9.53e-06	0.000281	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—thymus cancer	9.42e-06	0.000278	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—thymus cancer	9.32e-06	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—thymus cancer	8.75e-06	0.000258	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—thymus cancer	8.55e-06	0.000253	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—thymus cancer	7.79e-06	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—thymus cancer	7.71e-06	0.000228	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—thymus cancer	7.24e-06	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—thymus cancer	7.16e-06	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—thymus cancer	7.08e-06	0.000209	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—thymus cancer	6.95e-06	0.000205	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—thymus cancer	6.57e-06	0.000194	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—thymus cancer	6.12e-06	0.000181	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—thymus cancer	5.98e-06	0.000177	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—thymus cancer	5.17e-06	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—thymus cancer	5.05e-06	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—thymus cancer	4.95e-06	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—thymus cancer	4.64e-06	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—thymus cancer	4.6e-06	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—thymus cancer	4.18e-06	0.000123	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—thymus cancer	3.88e-06	0.000115	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—thymus cancer	3.03e-06	8.93e-05	CbGpPWpGaD
